Please login to the form below
report
This page shows the latest report news and features for those working in and with pharma, biotech and healthcare.
UK government expands coronavirus testing criteria
This decision was made after all four UK chief medical officers confirmed that anosmia was a symptom of COVID-19, after increasing anecdotal reports of the loss of taste and smell
Latest news
-
Octapharma cleared to start phase 3 trial of Octagam in COVID-19
Retrospective studies of case reports from Wuhan in China – the centre of the original outbreak of the new coronavirus – have suggested that high-dose treatment with IVIG could be effective in ... Octapharma says it hopes to report study results in
-
The mother of all nudges
Evidence Report/Technology Assessment No. 199. AHRQ Publication Number 11-E006. Rockville, MD.
-
New study identifies drugs that are safe to use in COVID-19 treatment
The European Medicines Agency also responded to these reports, and advised that while there is no scientific evidence that drugs like ibuprofen worsen COVID-19, it is closely monitoring the situation.
-
The march to sustainability
Strategically, every part of the business should set, communicate and report KPIs that measure sustainability goals.
-
BMS suspends new clinical trials as COVID-19 cases rise in US
While staff are being asked to operate from home, the company says its employees in China are starting to report back to work as the spread of the virus seems to
More from news
Approximately 25 fully matching, plus 2,263 partially matching documents found.
Latest Intelligence
-
After the watershed: the dos and don’ts of digital KPIs in a post-pandemic world
A common mistake is to make KPI reports way too technical, or rely on clever dashboards that tell you everything and nothing. ... The best approach is to plan two types of report – one at the strategic/executive level, the other more operational.
-
Emerging use cases of blockchain in healthcare and the life sciences
A recent report published by PreScouter, a Chicago-based research intelligence company, reviews three broad areas of blockchain deployment within the life sciences sector, including applications in drug development, supply chain ... Conclusions. The use
-
Biopharma and orphan drugs
The report suggests worldwide orphan drug sales will be worth $242bn by 2024, with the market growing by 12.3% which is approximately double the rate of the non-orphan drug
-
GSK forges ahead with its dynamic COPD and asthma portfolio
The promise includes a vaccine, which will report on phase 2 trials later this year, continuing work to identify biomarkers, and the start of a phase 3 trial of its therapy
-
COVID-19 hits supply chains
to a report the US-China Economic and Security Review Commission gave to Congress last October. ... The report paints a disconcerting picture of fraud, corruption and lack of cooperation vis-à-vis the Chinese pharmaceutical trade.
More from intelligence
Approximately 0 fully matching, plus 276 partially matching documents found.
Latest appointments
-
Pegasus gains a new managing director and digital lead
She will report to Simon Hackett, who has been MD of Pegasus since the agency was acquired by Ashfield.
-
Golin appoints new group managing director
As group managing director of both Golin and Virgo, Whittington will report directly to Matt Neale, Golin’s chief executive officer.
-
Porter Novelli adds Amber Tovey to London health team
Tovey will become second-in-command of Porter Novelli’s UK healthcare team, and will report directly to Ludivine Delattre, the agency’s head of health.
-
M Booth Health appoints Karen Strauss to lead strategy and innovation
She will report to M Booth Health CEO Timothy Bird, and will become one of 12 senior leaders at the consultancy, which specialises in public affairs, pharma marketing and advocacy. ... Strauss is also tasked with finding synergies between M Booth Health
-
Aurora boosts team with new hires and internal promotions
He has authored Aurora’s reports on collaboration in healthcare, was instrumental to the agency’s award-winning gender diversity work in 2019 and has engaged a wide range of public
More from appointments
Approximately 0 fully matching, plus 156 partially matching documents found.
Latest from PMHub
-
MarketsResearch.biz
MarketsResearch.Biz is a single destination for all the industry, company and country reports. ... We have a leading market intelligence team which accredits and provides the reports of some of the top publishers in the field of the technology industry.
-
COUCH Health demands the clinical research industry improves participant diversity
These include an in-depth research report following a series of lengthy interviews with representatives of a variety of cultures and religions; a comprehensive literature review; and a newly launched podcast
-
Research Partnership launches new patient Living with Psoriasis 2017 (EU) report
The report will consist of 30-minute online interviews with 600 patients and 15 qualitative interviews. ... It can be purchased as either a 5EU report (sample of 500 patients) or as a 7EU report (sample of 600 patients with the additional countries of
-
Research Partnership has published a new patient Living with Atopic Dermatitis (US) report
Living with Atopic Dermatitis (AD) is a report based on a new study conducted amongst adult sufferers and parents of child sufferers. ... The report consists of 45-minute quantitative and 30-minute qualitative interviews with 152 AD sufferers in total.
-
Research Partnership launches new patient Living with Atopic Dermatitis (US) 2017 report
The report will consist of 45-minute quantitative and 30-minute qualitative interviews with AD patients and caregivers.
More from PMHub
Approximately 5 fully matching, plus 279 partially matching documents found.
COVID-19 Updates and Daily News
Featured jobs
- Imperial College London to lead major coronavirus home testing programme
- ViiV takes on Gilead’s PReP dominance with HIV injectable data
- Moderna’s coronavirus vaccine hits first objectives
- Roche says antibody test for COVID-19 should be ready in May
- AZ secures capacity for one billion coronavirus vaccine doses
- UK’s new COVID-19 trial initiative fast-tracks BerGenBio’s bemcentinib
- AZ secures capacity for one billion coronavirus vaccine doses
- EMA starts review of MorphoSys’ tafasitamab for lymphoma
- Gilead, Galapagos dip on mixed ulcerative colitis data
- Roche makes protein degradation play with $135m Vividion deal
- Octapharma cleared to start phase 3 trial of Octagam in COVID-19
- UK government expands coronavirus testing criteria
PMHub
Aptus Health
Aptus Health is dedicated to advancing health engagement. The company offers end-to-end digital health engagement solutions spanning all areas of...
Latest intelligence
- OPEN Health attend EB World Congress—building on momentum and strength in numbers for epidermolysis bullosa
- Ben Speller shares his thoughts on the value of disease specific congresses...
- OPEN Health use PR to support clinical trial recruitment
- International Clinical Trials Day finds clinical research in the spotlight like never before, with any news coming from the many studies into potential vaccines and treatments for SARS-CoV-2...
- Covid-19: what could it mean for the diabetic population?
- Steve How and Oli Hudson, of Wilmington Healthcare, assess the scale of the diabetes crisis and how coronavirus might impact on it...
Quick links
Infographics
